BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prabavathy D, Swarnalatha Y, Ramadoss N. Lung cancer stem cells-origin, characteristics and therapy. Stem Cell Investig. 2018;5:6. [PMID: 29682513 DOI: 10.21037/sci.2018.02.01] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Chang MR, Rusanov DA, Arakelyan J, Alshehri M, Asaturova AV, Kireeva GS, Babak MV, Ang WH. Targeting emerging cancer hallmarks by transition metal complexes: Cancer stem cells and tumor microbiome. Part I. Coordination Chemistry Reviews 2023;477:214923. [DOI: 10.1016/j.ccr.2022.214923] [Reference Citation Analysis]
2 Liu Z, Shan S, Yuan Z, Wu F, Zheng M, Wang Y, Gui J, Xu W, Wang C, Ren T, Wen Z. Mitophagy bridges DNA sensing with metabolic adaption to expand lung cancer stem‐like cells. EMBO Reports 2022. [DOI: 10.15252/embr.202154006] [Reference Citation Analysis]
3 Wei Y, Li Y, Chen Y, Liu P, Huang S, Zhang Y, Sun Y, Wu Z, Hu M, Wu Q, Wu H, Liu F, She T, Ning Z. ALDH1: A potential therapeutic target for cancer stem cells in solid tumors. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1026278] [Reference Citation Analysis]
4 Brown G. Lessons to cancer from studies of leukemia and hematopoiesis. Front Cell Dev Biol 2022;10:993915. [DOI: 10.3389/fcell.2022.993915] [Reference Citation Analysis]
5 Shu X, Chen M, Liu S, Yu L, Sun L, Sun L, Ran Y. Palladin promotes cancer stem cell‐like properties in lung cancer by activating Wnt/ Β‐Catenin signaling. Cancer Medicine. [DOI: 10.1002/cam4.5192] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sher G, Masoodi T, Patil K, Akhtar S, Kuttikrishnan S, Ahmad A, Uddin S. Dysregulated FOXM1 Signaling in the regulation of cancer stem cells. Semin Cancer Biol 2022:S1044-579X(22)00180-8. [PMID: 35931301 DOI: 10.1016/j.semcancer.2022.07.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Tiong T, Weng P, Wang C, Setiawan SA, Yadav VK, Pikatan NW, Fong I, Yeh C, Hsu C, Kuo K. Targeting the SREBP-1/Hsa-Mir-497/SCAP/FASN Oncometabolic Axis Inhibits the Cancer Stem-like and Chemoresistant Phenotype of Non-Small Cell Lung Carcinoma Cells. IJMS 2022;23:7283. [DOI: 10.3390/ijms23137283] [Reference Citation Analysis]
8 Madsen KL, Gerke O, Høilund-carlsen PF, Olsen BB. Cisplatin-Resistant CD44+ Lung Cancer Cells Are Sensitive to Auger Electrons. IJMS 2022;23:7131. [DOI: 10.3390/ijms23137131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pustovalova M, Blokhina T, Alhaddad L, Chigasova A, Chuprov-Netochin R, Veviorskiy A, Filkov G, Osipov AN, Leonov S. CD44+ and CD133+ Non-Small Cell Lung Cancer Cells Exhibit DNA Damage Response Pathways and Dormant Polyploid Giant Cancer Cell Enrichment Relating to Their p53 Status. Int J Mol Sci 2022;23:4922. [PMID: 35563313 DOI: 10.3390/ijms23094922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Liu K, Gao X, Kang B, Liu Y, Wang D, Wang Y. The Role of Tumor Stem Cell Exosomes in Cancer Invasion and Metastasis. Front Oncol 2022;12:836548. [PMID: 35350566 DOI: 10.3389/fonc.2022.836548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Brown G. Oncogenes and the Origins of Leukemias. Int J Mol Sci 2022;23:2293. [PMID: 35216407 DOI: 10.3390/ijms23042293] [Reference Citation Analysis]
12 Haider M, Elsherbeny A, Pittalà V, Consoli V, Alghamdi MA, Hussain Z, Khoder G, Greish K. Nanomedicine Strategies for Management of Drug Resistance in Lung Cancer. IJMS 2022;23:1853. [DOI: 10.3390/ijms23031853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Aramini B, Masciale V, Grisendi G, Banchelli F, D’amico R, Dominici M, Haider KH. Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-19-2655-6_31] [Reference Citation Analysis]
14 Aramini B, Masciale V, Grisendi G, Banchelli F, D’amico R, Dominici M, Haider KH. Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer. Handbook of Stem Cell Therapy 2022. [DOI: 10.1007/978-981-16-6016-0_31-1] [Reference Citation Analysis]
15 Shokouhifar A, Firouzi J, Nouri M, Sarab GA, Ebrahimi M. NK cell upraise in the dark world of cancer stem cells. Cancer Cell Int 2021;21:682. [PMID: 34923966 DOI: 10.1186/s12935-021-02400-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mansoori M, Abdi Rad I, Mirzaei A, Tam KJ, Mohsen Hosseini S, Mahmodlu R, Mansouri F, Saeednejad Zanjani L, Madjd Z. Does GD2 synthase (GD2S) detect cancer stem cells in blood samples of breast carcinomas? J Appl Biomed 2021;19:181-9. [PMID: 34907737 DOI: 10.32725/jab.2021.019] [Reference Citation Analysis]
17 Parakh S, Ernst M, Poh AR. Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities. Cancers (Basel) 2021;13:6228. [PMID: 34944848 DOI: 10.3390/cancers13246228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
18 Hamad H, Olsen BB. Cannabidiol Induces Cell Death in Human Lung Cancer Cells and Cancer Stem Cells. Pharmaceuticals (Basel) 2021;14:1169. [PMID: 34832951 DOI: 10.3390/ph14111169] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
19 Kumbar VM, Muddapur UM, Bhat KG, Shwetha HR, Kugaji MS, Peram MR, Dindawar S. Cancer Stem Cell Traits in Tumor Spheres Derived from Primary Laryngeal Carcinoma Cell Lines. Contemp Clin Dent 2021;12:247-54. [PMID: 34759681 DOI: 10.4103/ccd.ccd_252_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Patergnani S, Missiroli S, Morciano G, Perrone M, Mantovani CM, Anania G, Fiorica F, Pinton P, Giorgi C. Understanding the Role of Autophagy in Cancer Formation and Progression Is a Real Opportunity to Treat and Cure Human Cancers. Cancers (Basel) 2021;13:5622. [PMID: 34830777 DOI: 10.3390/cancers13225622] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
21 Zhang L, Bing S, Dong M, Lu X, Xiong Y. Targeting ion channels for the treatment of lung cancer. Biochim Biophys Acta Rev Cancer 2021;1876:188629. [PMID: 34610420 DOI: 10.1016/j.bbcan.2021.188629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Mohan A, Raj Rajan R, Mohan G, Kollenchery Puthenveettil P, Maliekal TT. Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells. Front Cell Dev Biol 2021;9:668851. [PMID: 34150761 DOI: 10.3389/fcell.2021.668851] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
23 Tsai CY, Ko HJ, Huang CF, Lin CY, Chiou SJ, Su YF, Lieu AS, Loh JK, Kwan AL, Chuang TH, Hong YR. Ionizing Radiation Induces Resistant Glioblastoma Stem-Like Cells by Promoting Autophagy via the Wnt/β-Catenin Pathway. Life (Basel) 2021;11:451. [PMID: 34069945 DOI: 10.3390/life11050451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
24 Sumkhemthong S, Chamni S, Ecoy GU, Taweecheep P, Suwanborirux K, Prompetchara E, Chanvorachote P, Chaotham C. Jorunnamycin A Suppresses Stem-Like Phenotypes and Sensitizes Cisplatin-Induced Apoptosis in Cancer Stem-Like Cell-Enriched Spheroids of Human Lung Cancer Cells. Mar Drugs 2021;19:261. [PMID: 34063628 DOI: 10.3390/md19050261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Windmöller BA, Beshay M, Helweg LP, Flottmann C, Beermann M, Förster C, Wilkens L, Greiner JFW, Kaltschmidt C, Kaltschmidt B. Novel Primary Human Cancer Stem-Like Cell Populations from Non-Small Cell Lung Cancer: Inhibition of Cell Survival by Targeting NF-κB and MYC Signaling. Cells 2021;10:1024. [PMID: 33925297 DOI: 10.3390/cells10051024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
26 Li J, Wang J, Xie D, Pei Q, Wan X, Xing HR, Ye T. Characteristics of the PI3K/AKT and MAPK/ERK pathways involved in the maintenance of self-renewal in lung cancer stem-like cells. Int J Biol Sci 2021;17:1191-202. [PMID: 33867839 DOI: 10.7150/ijbs.57871] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
27 Leivas A, Risueño RM, Guzmán A, Sánchez-Vega L, Pérez M, Megías D, Fernández L, Alonso R, Pérez-Martínez A, Rapado I, Martínez-López J. Natural killer cells efficiently target multiple myeloma clonogenic tumor cells. Cancer Immunol Immunother 2021;70:2911-24. [PMID: 33693963 DOI: 10.1007/s00262-021-02901-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
28 Aramini B, Masciale V, Grisendi G, Banchelli F, D'Amico R, Maiorana A, Morandi U, Dominici M, Haider KH. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. Oncotarget 2021;12:230-50. [PMID: 33613850 DOI: 10.18632/oncotarget.27870] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
29 Musial C, Zaucha R, Kuban-Jankowska A, Konieczna L, Belka M, Marino Gammazza A, Baczek T, Cappello F, Wozniak M, Gorska-Ponikowska M. Plausible Role of Estrogens in Pathogenesis, Progression and Therapy of Lung Cancer. Int J Environ Res Public Health 2021;18:E648. [PMID: 33466597 DOI: 10.3390/ijerph18020648] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
30 Carvalho LS, Gonçalves N, Fonseca NA, Moreira JN. Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis. Pharmaceuticals (Basel) 2021;14:60. [PMID: 33451077 DOI: 10.3390/ph14010060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
31 Wang Q, Chang B, Li X, Zou Z. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis. J Clin Transl Hepatol 2021;9:90-8. [PMID: 33604259 DOI: 10.14218/JCTH.2020.00104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Steens J, Klar L, Hansel C, Slama A, Hager T, Jendrossek V, Aigner C, Klein D. The vascular nature of lung-resident mesenchymal stem cells. Stem Cells Transl Med 2021;10:128-43. [PMID: 32830458 DOI: 10.1002/sctm.20-0191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
33 Akbar Samadani A, Keymoradzdeh A, Shams S, Soleymanpour A, Elham Norollahi S, Vahidi S, Rashidy-Pour A, Ashraf A, Mirzajani E, Khanaki K, Rahbar Taramsari M, Samimian S, Najafzadeh A. Mechanisms of cancer stem cell therapy. Clin Chim Acta. 2020;510:581-592. [PMID: 32791136 DOI: 10.1016/j.cca.2020.08.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
34 Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies. Front Immunol 2020;11:1280. [PMID: 32849491 DOI: 10.3389/fimmu.2020.01280] [Cited by in Crossref: 149] [Cited by in F6Publishing: 165] [Article Influence: 74.5] [Reference Citation Analysis]
35 Giuli MV, Hanieh PN, Giuliani E, Rinaldi F, Marianecci C, Screpanti I, Checquolo S, Carafa M. Current Trends in ATRA Delivery for Cancer Therapy. Pharmaceutics 2020;12:E707. [PMID: 32731612 DOI: 10.3390/pharmaceutics12080707] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
36 Udoh K, Parte S, Carter K, Mack A, Kakar SS. Targeting of Lung Cancer Stem Cell Self-Renewal Pathway by a Small Molecule Verrucarin J. Stem Cell Rev Rep 2019;15:601-11. [PMID: 30835047 DOI: 10.1007/s12015-019-09874-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
37 Aramini B, Masciale V, Haider KH. Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective. World J Stem Cells 2020; 12(6): 406-421 [PMID: 32742559 DOI: 10.4252/wjsc.v12.i6.406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
38 Li Y, Zhang X, Zhu S, Dejene EA, Peng W, Sepulveda A, Seto E. HDAC10 Regulates Cancer Stem-Like Cell Properties in KRAS-Driven Lung Adenocarcinoma. Cancer Res 2020;80:3265-78. [PMID: 32540961 DOI: 10.1158/0008-5472.CAN-19-3613] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
39 Masciale V, Grisendi G, Banchelli F, D'Amico R, Maiorana A, Sighinolfi P, Brugioni L, Stefani A, Morandi U, Dominici M, Aramini B. Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. Front Oncol 2020;10:673. [PMID: 32500024 DOI: 10.3389/fonc.2020.00673] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
40 Choi HS, Kim SL, Kim JH, Lee DS. The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation. Int J Mol Sci 2020;21:E1014. [PMID: 32033067 DOI: 10.3390/ijms21031014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
41 Costantini L, Molinari R, Farinon B, Merendino N. Retinoic Acids in the Treatment of Most Lethal Solid Cancers. J Clin Med 2020;9:E360. [PMID: 32012980 DOI: 10.3390/jcm9020360] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
42 Wang W, Wang C, Xu H, Gao Y. Aldehyde Dehydrogenase, Liver Disease and Cancer. Int J Biol Sci 2020;16:921-34. [PMID: 32140062 DOI: 10.7150/ijbs.42300] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
43 Basati G, Khaksarian M, Abbaszadeh S, Lashgarian HE, Marzban A. Cancer stem cells and nanotechnological approaches for eradication. Stem Cell Investig 2019;6:38. [PMID: 31853454 DOI: 10.21037/sci.2019.10.07] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
44 Bearrood TE, Aguirre-Figueroa G, Chan J. Rational Design of a Red Fluorescent Sensor for ALDH1A1 Displaying Enhanced Cellular Uptake and Reactivity. Bioconjug Chem 2020;31:224-8. [PMID: 31738518 DOI: 10.1021/acs.bioconjchem.9b00723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
45 Qi H, Wang S, Wu J, Yang S, Gray S, Ng CSH, Du J, Underwood MJ, Li MY, Chen GG. EGFR-AS1/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer. Ther Adv Med Oncol 2019;11:1758835919855228. [PMID: 31275431 DOI: 10.1177/1758835919855228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
46 Kiratipaiboon C, Stueckle TA, Ghosh R, Rojanasakul LW, Chen YC, Dinu CZ, Rojanasakul Y. Acquisition of Cancer Stem Cell-like Properties in Human Small Airway Epithelial Cells after a Long-term Exposure to Carbon Nanomaterials. Environ Sci Nano 2019;6:2152-70. [PMID: 31372228 DOI: 10.1039/C9EN00183B] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
47 Vallette FM, Olivier C, Lézot F, Oliver L, Cochonneau D, Lalier L, Cartron P, Heymann D. Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer. Biochemical Pharmacology 2019;162:169-76. [DOI: 10.1016/j.bcp.2018.11.004] [Cited by in Crossref: 97] [Cited by in F6Publishing: 99] [Article Influence: 32.3] [Reference Citation Analysis]
48 Wang Y, Wang CH, Zhang YF, Zhu L, Lei HM, Tang YB. UPLC-MS-based metabolomics reveals metabolic dysregulation in ALDH1A1-overexpressed lung adenocarcinoma cells. Metabolomics 2019;15:52. [PMID: 30911937 DOI: 10.1007/s11306-019-1514-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
49 Zhang M, Tan S, Yu D, Zhao Z, Zhang B, Zhang P, Lv C, Zhou Q, Cao Z. Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway. Toxicology and Applied Pharmacology 2019;365:1-8. [DOI: 10.1016/j.taap.2019.01.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
50 Kashyap T, Pramanik KK, Nath N, Mishra P, Singh AK, Nagini S, Rana A, Mishra R. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer. Oral Oncol 2018;86:234-43. [PMID: 30409306 DOI: 10.1016/j.oraloncology.2018.09.028] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
51 Janetschek G, Weitzel D, Stein W, Müntefering H, Alken P. Prenatal diagnosis of neuroblastoma by sonography. Urology 1984;24:397-402. [PMID: 6385443 DOI: 10.1016/0090-4295(84)90224-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 0.7] [Reference Citation Analysis]